TBCE and metabolic dysfunction-associated steatotic liver disease: Similarly, in the portal vein of NAFLD patients, the expression levels of KCs and CD163+ are significantly elevated, suggesting a suppressive effect of butyrate on KCs (Schwenger et al., 2018; Wang Y. et al., 2021).